NCT05596812

A Novel Care Pathway in Women With "Low-risk" Gestational Diabetes Mellitus

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: Unity Health Toronto · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study is a randomized controlled trial to study the effect of the use of a risk stratification screening tool for high- and low-risk gestational diabetes mellitus (GDM), and the implementation of a new low-impact care pathway for women with low-risk GDM. The study will measure how well the screening tool and new care pathway are used, and the effect of the new low-impact care pathway on glycemic control, perinatal outcomes (large for gestational age, rate of labor induction, mode of delivery, obstetric anal sphincter injury, neonatal hypoglycemia, neonatal anthropometry) and health resource utilization in women with GDM that are at low-risk of dietary therapy failure.

Conditions

• Gestational Diabetes Mellitus in Pregnancy

Interventions

Type	Name	Description
OTHER	New Care Pathway	The New Care Pathway will include continuation of lifestyle and dietary modification, self-blood glucose monitoring, and routine prenatal care.

Timeline

• Start date: 2022-08-23
• Primary completion: 2023-08-01
• Completion: 2024-08-01
• First posted: 2022-10-27
• Last updated: 2022-10-27

Locations

1 site across 1 country: Canada